$3.38
At close: Sep 14, 5:00 PM EST
$3.48
0.102.96%
After Hours: Sep 11, 5:20 PM EST

Kalaris Therapeutics (KLRS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.50 | $-0.52 | $-0.55 | $-0.63 |
| Actual | $-0.48 | $-0.46 | $-0.44 | $-0.64 |
| Surprise | +4.00% | +11.5% | +20.0% | -1.59% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.52 | $-0.54 | $-0.54 | $-0.43 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.48 | $-0.50 | 4.00 % |
| Q1 | May 12, 2026 | $-0.46 | $-0.52 | 11.5 % |
| Q4 | Mar 17, 2026 | $-0.44 | $-0.55 | 20.0 % |
| Q3 | Nov 12, 2025 | $-0.64 | $-0.63 | -1.59 % |